We will also discuss their role in HSV and HIV infection, how HSV infection increases the risk of HIV acquisition, and how CD4+ TRMs in the genital tract could be used to enhance therapeutic strategies or contribute to vaccine development in the absence of an effective vaccine against HIV or HSV. This evidence concerns the gene CD4 and HIV infectious disease.